Development of a validated liquid chromato-graphy–tandem mass spectrometry assay for the quantification of simvastatin acid, the active metabolite of simvastatin, in human plasma
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCIScopus
- 저널 순위
- Scopus Q4
- 저널
- Translational and Clinical Pharmacology24(1) · pp.22 · 2016
- 피인용
- KCI 0
- ISSN
- 2289-0882
저자
- 박현정제1저자서울아산병원
- 황애경서울아산병원
- 김아름서울아산병원
- 김수현서울아산병원
- 김은화서울아산병원
- 조상헌인하대학교
- 김종률인제대학교
- 최상민부산대학교병원
- 정진아인제대학교부속부산백병원
- 진석준울산대학교
- 배균섭울산대학교
- 임형석교신저자울산대학교
초록
Simvastatin is a lipid-lowering drug that is metabolized to its active metabolite simvastatin acid (SA). We developed and validated a sensitive liquid chromatography–tandem mass spectrometry (LC/MS/MS) method to quantitate SA in human plasma using a liquid–liquid extraction method with methanol. The protonated analytes generated in negative ion mode were monitored by mul-tiple reaction monitoring. Using 500-mL plasma aliquots, SA was quantified in the range of 0.1–100 ng/mL. Calibration was performed by internal standardization with lovastatin acid, and regression curves were generated using a weighting factor of 1/x². The linearity, precision, and accuracy of this assay for each compound were validated using quality control samples consisting of mixtures of SA (0.1, 0.5, 5, and 50 ng/mL) and plasma. The intra-batch accuracy was 95.3–107.8%, precision was –2.2% to –3.7%, and linearity (r²) was over 0.998 in the standard calibration range. The chromato¬graphic running time was 3.0 min. This method sensitively and reliably measured SA concentra¬tions in human plasma and was successfully used in clinical pharmacokinetic studies of simvastatin in healthy Korean adult male volunteers.
키워드
식별자
- KCI
- ART002091293



로그인
연구물 목록으로